Should I buy or sell RVL Pharmaceuticals stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RVL Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RVLP shares. View RVLP analyst ratings or view top-rated stocks .

What is RVL Pharmaceuticals' stock price target for 2024?

1 brokers have issued 12-month target prices for RVL Pharmaceuticals' stock. Their RVLP share price targets range from $2.00 to $3.00. On average, they predict the company's share price to reach $2.50 in the next year. View analysts price targets for RVLP or view top-rated stocks among Wall Street analysts .

When is RVL Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our RVLP earnings forecast .

How were RVL Pharmaceuticals' earnings last quarter?

RVL Pharmaceuticals plc (NASDAQ:RVLP) announced its quarterly earnings data on Monday, March, 20th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.03. The company earned $9.81 million during the quarter, compared to the consensus estimate of $12.10 million. During the same quarter last year, the business earned ($0.26) EPS.

NASDAQ:RVLP

RVL Pharmaceuticals (RVLP) Stock Price, News & Analysis

→ Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad)

Free RVLP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.00
▼
$0.19
52-Week Range: N/A

Volume: 63.96 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.50

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Social Media

Get RVL Pharmaceuticals alerts:

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

About RVL Pharmaceuticals Stock (NASDAQ:RVLP)

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

RVLP Stock News Headlines

March 2, 2024 | seekingalpha.com

RVLPQ RVL Pharmaceuticals plc

January 11, 2024 | morningstar.com

RVL Pharmaceuticals PLC RVLPQ

April 17, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

October 13, 2023 | marketwatch.com

RVL Pharmaceuticals Shares Plummet 50% as Subsidiaries File For Bankruptcy

October 12, 2023 | benzinga.com

Specialty Pharma Firm RVL Pharmaceuticals Subsidiaries File for Bankruptcy

October 12, 2023 | markets.businessinsider.com

RVL Subsidiaries To Effectuate Change Of Control; RVLP Ordinary Shares Expected To Be Cancelled

October 12, 2023 | finance.yahoo.com

RVL Pharmaceuticals Subsidiaries File for Bankruptcy

October 6, 2023 | investorplace.com

Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?

April 17, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

August 23, 2023 | finance.yahoo.com

Unmasking the Value Trap: A Deep Dive into RVL Pharmaceuticals PLC

August 23, 2023 | finance.yahoo.com

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 21, 2023 | markets.businessinsider.com

RVL Pharmaceuticals (RVLP) Gets a Buy from H.C. Wainwright

August 16, 2023 | benzinga.com

Crude Oil Falls Sharply; RVL Pharmaceuticals Shares Plummet

August 16, 2023 | msn.com

RVLP: Second Quarter Results

August 16, 2023 | marketwatch.com

RVL Pharmaceuticals Shares Hit New Lows After Stock Sale >RVLP

August 16, 2023 | msn.com

RVL Pharmaceuticals shares fall after pricing $5M stock offering

August 16, 2023 | finance.yahoo.com

Downgrade: Here's How Analysts See RVL Pharmaceuticals plc (NASDAQ:RVLP) Performing In The Near Term

August 16, 2023 | finance.yahoo.com

RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

August 15, 2023 | finance.yahoo.com

Q2 2023 RVL Pharmaceuticals PLC Earnings Call

August 14, 2023 | msn.com

RVLP: Revenue Dip Prompts Spending Reversal

August 14, 2023 | finance.yahoo.com

RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review

July 20, 2023 | finance.yahoo.com

Insiders Re-Evaluate Their US$1.6m Stock Purchase As RVL Pharmaceuticals Falls To US$43m

July 5, 2023 | msn.com

RVL Pharma (NASDAQ:RVLP) Rises on Mulling A Strategic Transaction

July 5, 2023 | benzinga.com

RVL Pharmaceuticals shares are trading higher after the company said it has been considering certain strategic alternatives.

June 15, 2023 | finance.yahoo.com

RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting

June 2, 2023 | finance.yahoo.com

Shareholders in RVL Pharmaceuticals (NASDAQ:RVLP) are in the red if they invested three years ago

May 13, 2023 | finance.yahoo.com

Time To Worry? Analysts Just Downgraded Their RVL Pharmaceuticals plc (NASDAQ:RVLP) Outlook

See More Headlines

Receive RVLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RVL Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/20/2023
Today: 4/17/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:RVLP
CUSIP: N/A
CIK: 1739426
Web: www.osmotica.com
Phone: (908) 809-1300
Fax: N/A
Employees: 125
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $2.50
High Stock Price Target: $3.00
Low Stock Price Target: $2.00
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $49.72 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.51 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 111,410,000
Free Float: 106,504,000
Market Cap: N/A
Optionable: Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Brian A. Markison (Age 64)
Chairman, President, CEO & Principal Financial Officer
Comp: $525k
Mr. James D. Schaub (Age 41)
Executive VP & COO
Comp: $367.2k
Mr. Christopher A. Klein (Age 58)
General Counsel & Secretary
Comp: $367.2k
Mr. Michael J. DePetris (Age 46)
Principal Accounting Officer
Mr. Jarret Miller
Executive Vice President of Human Resources

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

RVLP Stock Analysis - Frequently Asked Questions

Should I buy or sell RVL Pharmaceuticals stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RVL Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RVLP shares.
View RVLP analyst ratings or view top-rated stocks.
What is RVL Pharmaceuticals' stock price target for 2024?: 1 brokers have issued 12-month target prices for RVL Pharmaceuticals' stock. Their RVLP share price targets range from $2.00 to $3.00. On average, they predict the company's share price to reach $2.50 in the next year.
View analysts price targets for RVLP or view top-rated stocks among Wall Street analysts.
When is RVL Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our RVLP earnings forecast.
How were RVL Pharmaceuticals' earnings last quarter?: RVL Pharmaceuticals plc (NASDAQ:RVLP) announced its quarterly earnings data on Monday, March, 20th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.03. The company earned $9.81 million during the quarter, compared to the consensus estimate of $12.10 million. During the same quarter last year, the business earned ($0.26) EPS.

This page (NASDAQ:RVLP) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

RVL Pharmaceuticals (RVLP) Stock Price, News & Analysis

About RVL Pharmaceuticals Stock (NASDAQ:RVLP)

RVLP Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

RVLP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info